340 related articles for article (PubMed ID: 30592286)
1. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.
Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W
Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
Yang S; Li X; Shen W; Hu H; Li C; Han G
J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
[TBL] [Abstract][Full Text] [Related]
3. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2.
Li J; Yuan J; Yuan X; Zhao J; Zhang Z; Weng L; Liu J
Int J Oncol; 2016 Feb; 48(2):541-50. PubMed ID: 26648487
[TBL] [Abstract][Full Text] [Related]
5. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
Jiang G; Wen L; Deng W; Jian Z; Zheng H
Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
7. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
8. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Ji H; Sang M; Liu F; Ai N; Geng C
Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity.
Yao H; Hou G; Wang QY; Xu WB; Zhao HQ; Xu YC
Int J Oncol; 2020 Jan; 56(1):85-100. PubMed ID: 31746422
[TBL] [Abstract][Full Text] [Related]
10. Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression.
Wang P; Liu X; Han G; Dai S; Ni Q; Xiao S; Huang J
Cell Cycle; 2019 Sep; 18(18):2359-2376. PubMed ID: 31387451
[No Abstract] [Full Text] [Related]
11. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1.
Zhang L; Zhang T; Deng Z; Sun L
Oncol Rep; 2019 Mar; 41(3):1669-1677. PubMed ID: 30664185
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
Chen DL; Lu YX; Zhang JX; Wei XL; Wang F; Zeng ZL; Pan ZZ; Yuan YF; Wang FH; Pelicano H; Chiao PJ; Huang P; Xie D; Li YH; Ju HQ; Xu RH
Theranostics; 2017; 7(19):4836-4849. PubMed ID: 29187907
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
He J; Wang J; Li S; Li T; Chen K; Zhang S
Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger E‑box binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma.
Li Q; Ma L; Wu Z; Wang G; Huang Q; Shen Z; Yu R
Mol Med Rep; 2019 Jun; 19(6):4545-4552. PubMed ID: 30957184
[TBL] [Abstract][Full Text] [Related]
16. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.
Zhu W; Luo X; Fu H; Liu L; Sun P; Wang Z
Pathol Res Pract; 2019 Oct; 215(10):152577. PubMed ID: 31405759
[TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of
Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF
World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860
[TBL] [Abstract][Full Text] [Related]
18. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.
Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T
Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885
[TBL] [Abstract][Full Text] [Related]
19. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
[TBL] [Abstract][Full Text] [Related]
20. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
